Back to Jefferies Financial Group Inc. Jefferies Financial Group Inc.

RYTMRYTM

Showing 4 of 10 quarters

Position history for Jefferies Financial Group Inc.Jefferies Financial Group Inc.'s holdings in Rhythm Pharmaceuticals, Inc.

No. Jefferies Financial Group exited its RYTM (Rhythm Pharmaceuticals) position in Q2 2025. Its Q1 2025 13F listed 17,100 shares worth $905,787. Jefferies Financial Group first reported RYTM in Q1 2023 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$943,020

Total Shares Change

-18,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$63.19
0
2025-Q1
New
17,100
—
$905,7870.0%$52.97
34
2024-Q4
Exited
0
-100.0%
$00.0%$55.98
0
2024-Q3
New
18,000
—
$943,0200.0%$52.39
35

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used